Details

Last Funding Type

Series B

Last Funding Money Raised

$1.20M

Industries

Biotechnology

Founded date

Jan 1, 1999

Number Of Employee

1 - 10

Operating Status

Active

Renovar engages in the discovery and development of diagnostic tests based on a portfolio of protein biomarkers for kidney disease and transplant monitoring. It provides a portfolio of protein biomarkers that indicate kidney injury using its urinary immunoassay platform; and CFSE Flow Kit that is used for tracking eight generations of cell proliferation in-vivo and in-vitro for mouse and human cells by flow cytometry. The company also offers custom assays and study services to support research activities, including biomarker selection and assay panel development, study design, data analysis, and samples testing. Renovar, Inc. was founded in 1999 and is headquartered in Appleton, Wisconsin.